During the past decade, Lviv Regional Clinical Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 17 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 13 clinical trials were completed. i.e. 108.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lviv Regional Clinical Hospital" #1 sponsor was "Celgene" with 9 trials, followed by "Actelion" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lviv Regional Clinical Hospital" #1 collaborator was "AOCMF" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lviv Regional Clinical Hospital" are "Crohn Disease" (5 trials), "Pulmonary Arterial Hypertension" (5 trials), "Ulcerative Colitis" (4 trials), "Hypertension, Pulmonary" (3 trials) and "Multiple Sclerosis" (3 trials). Many other conditions were trialed in "Lviv Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Lviv Regional Clinical Hospital" are "Drug" (37 trials), "Other" (6 trials), "Biological" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ozanimod" (6 trials), "Etrolizumab" (4 trials), "RPC1063" (3 trials) and "Selexipag" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lviv Regional Clinical Hospital" are 39 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lviv Regional Clinical Hospital". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 19 completed trials in Lviv Regional Clinical Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Lviv Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".